Search Results - "Lambert, Bieke"

Refine Results
  1. 1
  2. 2

    Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence by Decaestecker, Karel, De Meerleer, Gert, Lambert, Bieke, Delrue, Louke, Fonteyne, Valérie, Claeys, Tom, De Vos, Filip, Huysse, Wouter, Hautekiet, Arne, Maes, Gaethan, Ost, Piet

    Published in Radiation oncology (London, England) (12-06-2014)
    “…To assess the outcome of prostate cancer (PCa) patients diagnosed with oligometastatic disease at recurrence and treated with stereotactic body radiotherapy…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Quantitative Imaging for Targeted Radionuclide Therapy Dosimetry - Technical Review by Li, Tiantian, Ao, Edwin C I, Lambert, Bieke, Brans, Boudewijn, Vandenberghe, Stefaan, Mok, Greta S P

    Published in Theranostics (01-01-2017)
    “…Targeted radionuclide therapy (TRT) is a promising technique for cancer therapy. However, in order to deliver the required dose to the tumor, minimize…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    In vitro 2-deoxy-2-[18F]fluoro-D-glucose uptake: practical considerations by Mertens, Koen, Mees, Gilles, Lambert, Bieke, Van de Wiele, Christophe, Goethals, Ingeborg

    Published in Cancer biotherapy & radiopharmaceuticals (01-04-2012)
    “…In oncology 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]-FDG), a glucose analogue, is the most used positron emission tomography (PET) tracer. There are however…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11

    Guidelines on nuclear medicine imaging in neuroblastoma by Bar-Sever, Zvi, Biassoni, Lorenzo, Shulkin, Barry, Kong, Grace, Hofman, Michael S., Lopci, Egesta, Manea, Irina, Koziorowski, Jacek, Castellani, Rita, Boubaker, Ariane, Lambert, Bieke, Pfluger, Thomas, Nadel, Helen, Sharp, Susan, Giammarile, Francesco

    “…Nuclear medicine has a central role in the diagnosis, staging, response assessment and long-term follow-up of neuroblastoma, the most common solid extracranial…”
    Get full text
    Journal Article
  12. 12

    Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer by Ost, Piet, Decaestecker, Karel, Lambert, Bieke, Fonteyne, Valérie, Delrue, Louke, Lumen, Nicolaas, Ameye, Filip, De Meerleer, Gert

    Published in The Prostate (01-02-2014)
    “…BACKGROUND In non‐castrate prostate cancer (PCa), the prognostic value of the number of metastases on prostate cancer‐specific survival (PCSS) is not well…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy by Berkovic, Patrick, De Meerleer, Gert, Delrue, Louke, Lambert, Bieke, Fonteyne, Valérie, Lumen, Nicolaas, Decaestecker, Karel, Villeirs, Geert, Vuye, Philippe, Ost, Piet

    Published in Clinical genitourinary cancer (01-03-2013)
    “…Micro-Abstract Patients with metastatic prostate cancer are uniformly treated with castration (surgically or medically), which is associated with numerous side…”
    Get full text
    Journal Article